📣 VC round data is live. Check it out!
- Public Comps
- Lumibird
Lumibird Valuation Multiples
Discover revenue and EBITDA valuation multiples for Lumibird and similar public comparables like Japan Lifeline, Tactile Medical, Mesa Laboratories, SI-BONE and more.
Lumibird Overview
About Lumibird
Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.
Founded
1970
HQ

Employees
1.1K
Website
Financials (LTM)
EV
$665M
Valuation Multiples
Start free trialLumibird Financials
Lumibird reported last 12-month revenue of $271M and EBITDA of $56M.
In the same LTM period, Lumibird generated $56M in EBITDA and $20M in net income.
Revenue (LTM)
Lumibird P&L
In the most recent fiscal year, Lumibird reported revenue of $270M and EBITDA of $52M.
Lumibird is profitable as of last fiscal year, with gross margin of 64%, EBITDA margin of 19%, and net margin of 6%.
Financial data powered by Morningstar, Inc.
Lumibird Stock Performance
Lumibird has current market cap of $565M, and enterprise value of $665M.
Market Cap Evolution
Lumibird's stock price is $25.59.
Lumibird share price increased by 1.9% in the last 30 days, and by 50.9% in the last year.
Lumibird has an EPS (earnings per share) of $0.77.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $665M | $565M | 0.0% | 1.9% | -3.7% | 50.9% | $0.77 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialLumibird Valuation Multiples
Lumibird trades at 2.5x EV/Revenue multiple, and 11.9x EV/EBITDA.
EV / Revenue (LTM)
Lumibird Financial Valuation Multiples
As of May 11, 2026, Lumibird has market cap of $565M and EV of $665M.
Lumibird has a P/E ratio of 28.2x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Lumibird Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Lumibird Margins & Growth Rates
Lumibird grew revenue by 8% and EBITDA by 19% in the last fiscal year.
In the most recent fiscal year, Lumibird reported gross margin of 64%, EBITDA margin of 19%, and net margin of 6%.
Lumibird Margins
Lumibird Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Lumibird Operational KPIs
Lumibird's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.
Lumibird's Rule of 40 is 29% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Lumibird's Rule of X is 40% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Lumibird Competitors
Lumibird competitors include Japan Lifeline, Tactile Medical, Mesa Laboratories, SI-BONE, Sofwave Medical, MiMedx Group, Cytek Biosciences, Castle Biosciences, Cerus and IBA Group.
Most Lumibird public comparables operate across Medical Devices, Medical Imaging & Diagnostics and DeepTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.4x | 1.3x | 5.7x | 5.3x | |||
| 1.5x | 1.5x | 11.2x | 10.8x | |||
| 3.0x | 2.9x | 12.9x | 11.9x | |||
| 2.2x | 2.0x | 48.5x | 45.8x | |||
| 6.3x | — | 73.0x | — | |||
| 0.9x | 1.1x | 3.7x | 5.2x | |||
| 1.8x | 1.8x | (544.3x) | (1260.1x) | |||
| 1.1x | 1.1x | 8.7x | 12.2x | |||
This data is available for Pro users. Sign up to see all Lumibird competitors and their valuation data. Start Free Trial | ||||||
Lumibird M&A Activity
Lumibird has acquired 1 company to date.
Last acquisition by Lumibird was on October 22nd 2024. Lumibird acquired Continuum for $6M (EV/Revenue multiple of ).
Latest Acquisitions by Lumibird
| Description | Continuum is a manufacturer of high-power lasers for scientific research, industrial material processing, and commercial applications. Based in the United States, the company produces Nd:YAG, dye, and titanium-sapphire lasers operating at wavelengths from ultraviolet to infrared. Continuum supplies systems to laboratories, semiconductor fabs, and medical device producers worldwide. |
| HQ Country | |
| HQ City | San Jose, CA |
| Deal Date | 22 Oct 2024 |
| Valuation | $6M |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all Lumibird acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Lumibird
| When was Lumibird founded? | Lumibird was founded in 1970. |
| Where is Lumibird headquartered? | Lumibird is headquartered in France. |
| How many employees does Lumibird have? | As of today, Lumibird has over 1K employees. |
| Is Lumibird publicly listed? | Yes, Lumibird is a public company listed on Euronext Paris. |
| What is the stock symbol of Lumibird? | Lumibird trades under LBIRD ticker. |
| When did Lumibird go public? | Lumibird went public in 1997. |
| Who are competitors of Lumibird? | Lumibird main competitors include Japan Lifeline, Tactile Medical, Mesa Laboratories, SI-BONE, Sofwave Medical, MiMedx Group, Cytek Biosciences, Castle Biosciences, Cerus, IBA Group. |
| What is the current market cap of Lumibird? | Lumibird's current market cap is $565M. |
| What is the current revenue of Lumibird? | Lumibird's last 12 months revenue is $271M. |
| What is the current revenue growth of Lumibird? | Lumibird revenue growth (NTM/LTM) is 10%. |
| What is the current EV/Revenue multiple of Lumibird? | Current revenue multiple of Lumibird is 2.5x. |
| Is Lumibird profitable? | Yes, Lumibird is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Lumibird? | Lumibird's last 12 months EBITDA is $56M. |
| What is Lumibird's EBITDA margin? | Lumibird's last 12 months EBITDA margin is 21%. |
| What is the current EV/EBITDA multiple of Lumibird? | Current EBITDA multiple of Lumibird is 11.9x. |
| What is the current FCF of Lumibird? | Lumibird's last 12 months FCF is $18M. |
| What is Lumibird's FCF margin? | Lumibird's last 12 months FCF margin is 7%. |
| What is the current EV/FCF multiple of Lumibird? | Current FCF multiple of Lumibird is 37.8x. |
| How many companies Lumibird has acquired to date? | As of May 2026, Lumibird has acquired 1 company. |
| What was the largest acquisition by Lumibird? | $6M acquisition of Continuum on 22nd October 2024 was the largest M&A Lumibird has done to date. |
| What companies Lumibird acquired? | Lumibird acquired Continuum. |
| In how many companies Lumibird has invested to date? | Lumibird hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Lumibird
Lists including Lumibird
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
